Zheng Wei
Zheng Wei, Redwood City, CA US
Patent application number | Description | Published |
---|---|---|
20080261966 | BIS-ARYL SULFONAMIDES - Compounds are provided that act as potent antagonists of chemokine receptors. The compounds are generally aryl sulfonamide derivatives and are useful in pharmaceutical compositions, methods for the treatment of chemokine receptor-mediated diseases, and as controls in assays for the identification of chemokine antagonists. | 10-23-2008 |
20080293717 | ARYL SULFONAMIDES - Compounds are provided that act as potent antagonists of the CCR9 receptor, and which have been further confirmed in animal testing for inflammation, one of the hallmark disease states for CCR9. The compounds are generally aryl sulfonamide derivatives and are useful in pharmaceutical compositions, methods for the treatment of CCR9-mediated diseases, and as controls in assays for the identification of CCR9 antagonists. | 11-27-2008 |
20090118307 | Aryl Sulfonamides - Compounds are provided that act as potent antagonists of the CCR9 receptor, and which have been further confirmed in animal testing for inflammation, one of the hallmark disease states for CCR9. The compounds are generally aryl sulfonamide derivatives and are useful in pharmaceutical compositions, methods for the treatment of CCR9-mediated diseases, and as controls in assays for the identification of CCR9 antagonists. | 05-07-2009 |
20090270616 | ARYL SULFONAMIDES - Compounds are provided that act as potent antagonists of the CCR9 receptor, and which have been further confirmed in animal testing for inflammation, one of the hallmark disease states for CCR9. The compounds are generally aryl sulfonamide derivatives and are useful in pharmaceutical compositions, methods for the treatment of CCR9-mediated diseases, and as controls in assays for the identification of CCR9 antagonists. | 10-29-2009 |
20100227902 | BIS-ARYL SULFONAMIDES - Compounds are provided that act as potent antagonists of chemokine receptors. The compounds are generally aryl sulfonamide derivatives and are useful in pharmaceutical compositions, methods for the treatment of chemokine receptor-mediated diseases, and as controls in assays for the identification of chemokine antagonists. | 09-09-2010 |
20110021523 | ARYL SULFONAMIDES - Compounds are provided that act as potent antagonists of the CCR9 receptor, and which have been further confirmed in animal testing for inflammation, one of the hallmark disease states for CCR9. The compounds are generally aryl sulfonamide derivatives and are useful in pharmaceutical compositions, methods for the treatment of CCR9-mediated diseases, and as controls in assays for the identification of CCR9 antagonists. | 01-27-2011 |
20110257183 | BIS-ARYL SULFONAMIDES - Compounds are provided that act as potent antagonists of chemokine receptors. The compounds are generally aryl sulfonamide derivatives and are useful in pharmaceutical compositions, methods for the treatment of chemokine receptor-mediated diseases, and as controls in assays for the identification of chemokine antagonists. | 10-20-2011 |
Zheng Wei, Union City, CA US
Patent application number | Description | Published |
---|---|---|
20090163498 | Aryl Sulfonamides - Compounds are provided that act as potent antagonists of the CCR9 receptor, and which have been further confirmed in animal testing for inflammation, one of the hallmark disease states for CCR9. The compounds are generally aryl sulfonamide derivatives and are useful in pharmaceutical compositions, methods for the treatment of CCR9-mediated diseases, and as controls in assays for the identification of CCR9 antagonists. | 06-25-2009 |
20100056509 | HETEROARYL SULFONAMIDES AND CCR2 - Compounds are provided that act as potent antagonists of the CCR2 receptor. Animal testing demonstrates that these compounds are useful for treating inflammation, a hallmark disease for CCR2. The compounds are generally aryl sulfonamide derivatives and are useful in pharmaceutical compositions, methods for the treatment of CCR2-mediated diseases, and as controls in assays for the identification of CCR2 antagonists. | 03-04-2010 |
20100234364 | CCR2 INHIBITORS AND METHODS OF USE THEREOF - Compounds are provided that act as potent antagonists of the CCR2 or CCR9 receptor. Animal testing demonstrates that these compounds are useful for treating inflammation, a hallmark disease for CCR2 and CCR9. The compounds are generally aryl sulfonamide derivatives and are useful in pharmaceutical compositions, methods for the treatment of CCR2-mediated diseases, CCR9-mediated diseases, as controls in assays for the identification of CCR2 antagonists, and as controls in assays for the identification of CCR9 antagonists. | 09-16-2010 |
20120014997 | ARYL SULFONAMIDES - Compounds are provided that act as potent antagonists of the CCR9 receptor, and which have been further confirmed in animal testing for inflammation, one of the hallmark disease states for CCR9. The compounds are generally aryl sulfonamide derivatives and are useful in pharmaceutical compositions, methods for the treatment of CCR9-mediated diseases, and as controls in assays for the identification of CCR9 antagonists. | 01-19-2012 |
20130267492 | ARYL SULFONAMIDES - Compounds are provided that act as potent antagonists of the CCR9 receptor, and which have been further confirmed in animal testing for inflammation, one of the hallmark disease states for CCR9. The compounds are generally aryl sulfonamide derivatives and are useful in pharmaceutical compositions, methods for the treatment of CCR9-mediated diseases, and as controls in assays for the identification of CCR9 antagonists. | 10-10-2013 |
20140031348 | HETEROARYL SULFONAMIDES AND CCR2/CCR9 - Compounds are provided that act as potent antagonists of the CCR2 receptor. Animal testing demonstrates that these compounds are useful for treating inflammation, a hallmark disease for CCR2. The compounds are generally aryl sulfonamide derivatives and are useful in pharmaceutical compositions, methods for the treatment of CCR2-mediated diseases, and as controls in assays for the identification of CCR2 antagonists. | 01-30-2014 |
20150080351 | ARYL SULFONAMIDES - Compounds are provided that act as potent antagonists of the CCR9 receptor, and which have been further confirmed in animal testing for inflammation, one of the hallmark disease states for CCR9. The compounds are generally aryl sulfonamide derivatives and are useful in pharmaceutical compositions, methods for the treatment of CCR9-mediated diseases, and as controls in assays for the identification of CCR9 antagonists. | 03-19-2015 |
Zheng Wei, Shanghai CN
Patent application number | Description | Published |
---|---|---|
20100145477 | METHOD AND APPARATUS FOR COMMAND SYNCHRONIZATION - Method and apparatus for command synchronization is described. In some embodiments, a remote system system may set up a user interactive session with a local device according to a user interaction protocol. The remote system may insert a predetermined execution time into a first command and send the first command to a local device according to the user interaction protocol. The first command, when executed on the local device, causes a second command compliant with the user interaction protocol to execute on the local device at the predetermined execution time. | 06-10-2010 |
Zheng Wei, Fuzhou City CN
Patent application number | Description | Published |
---|---|---|
20100041896 | Macrolide compound with bis-oxazoly - This patent mainly provides a new macrolide compound named FW-04-806, which contains bis-oxazoly in molecule. FW-04-806, a bis-oxazolyl macrolide compound extracted and separated from the ferment liquid of | 02-18-2010 |
Zheng Wei, San Diego, CA US
Patent application number | Description | Published |
---|---|---|
20110118248 | Heteroaryl sulfonamides and CCR2/CCR9 - Compounds are provided that act as potent antagonists of the CCR2 receptor. Animal testing demonstrates that these compounds are useful for treating inflammation, a hallmark disease for CCR2. The compounds are generally aryl sulfonamide derivatives and are useful in pharmaceutical compositions, methods for the treatment of CCR2-mediated diseases, and as controls in assays for the identification of CCR2 antagonists. | 05-19-2011 |
Zheng Wei, Guangdong CN
Patent application number | Description | Published |
---|---|---|
20110299624 | DEVICE AND METHOD FOR REALIZING PREFIX CODE CONSTRUCTION - The present invention provides a device and method for realizing prefix code construction. The device includes a sort indexer, a generator and a sequence regulator. The sort indexer is used to sort a group of received code lengths to obtain a group of sorted code lengths, and record the position correspondence relationship. The generator receives the sorted code lengths and orderly generates the prefix codes. Except that the first prefix code is preconfigured, the generator generates a current prefix code by adding one to the adjacently previous prefix code and then shifting left by a certain number of bits. When the current prefix code is generated, the generator simultaneously judges whether the adjacently previous prefix code is identical to the current prefix code from the high bit, if yes, the error information is outputted; otherwise the prefix codes corresponding to the sorted code lengths are generated. The sequence regulator is used to receive the prefix codes corresponding to the sorted code lengths, and regulates the sequence of the prefix codes corresponding to the sorted code lengths according to the position correspondence relationship recorded by the sort indexer to obtain the prefix codes corresponding to the code lengths. The solution can report error in time. | 12-08-2011 |
Zheng Wei, Bellevue, WA US
Patent application number | Description | Published |
---|---|---|
20140372412 | DYNAMIC FILTERING SEARCH RESULTS USING AUGMENTED INDEXES - Methods and systems for using dynamic filtering for searching content items in augmented indexes are provided. A search query is received. The search query is associated with a sort attribute whose order is different from the implicit ordering of content items within the augmented indexes. A plurality of search query elements for the search query is identified. The plurality of search query elements includes the sort attribute having one or more attribute-range-elements each associated with an attribute-range of the sort attribute. An augmented index for searching the query elements is referenced. The augmented index comprises the one or more attribute-range-elements that map to one or more content items having an attribute-value in the attribute-range of the one or more attribute-range elements. Matching content items that satisfy the search query are identified based on selecting matching content items in the augmented index and dynamically filtering the matching content items into a matched-group using the one or more attribute-range-elements. | 12-18-2014 |
Zheng Wei, Pudong CN
Patent application number | Description | Published |
---|---|---|
20150100133 | IMPLANTED SYSTEM FOR TREATING SINUSITIS OR ALLERGIC RHINITIS - An implanted system for treating sinusitis or allergic rhinitis is provided, wherein the implanted system has a circumferentially extending wall formed of a biodegradable polymer, and the wall includes a plurality of interspaces, with biodegradable fiber bundles containing drugs interspersed in the interspaces. The implanted system formed of the biodegradable polymer can provide a sufficient normal force perpendicular to the external surface during a compression, and prevent the supported channel from being closed after the release in a location for the implantation (a location of pathological changes or ostium of the sinus). The implanted system formed of the biodegradable polymer has an axial internal bore to guarantee the aeration for the nasal cavity after the implantation. The implanted system formed of the biodegradable polymer can be naturally degraded in the nasal cavity. Compared with prior stents which cannot directly contact with certain locations of pathological changes, the biodegradable fiber bundles containing drugs carried on the implanted system can reach those locations of pathological changes to optimize the therapeutic effect. | 04-09-2015 |
20150265813 | BALLOON SYSTEM FOR TREATING SINUSITIS OR ALLERGIC RHINITIS - A balloon system for treating sinusitis or allergic rhinitis includes a central inner tube, a balloon to be filled and a balloon catheter outer tube, all of which axially extend. The central inner tube includes a distal end part and a proximal end part detachably connected with each other by a connector in an axial direction. A first end of the balloon is connected to the distal end part, and a second end of the balloon and the balloon catheter outer tube are detachably connected with each other by the connector. The balloon catheter outer tube is radially outwardly spaced from the proximal end part, and the connector includes a first grommet and a second grommet rotating coaxially and relatively fixed with each other in axial direction. Each of the first grommet and second grommet has at least one gas port. | 09-24-2015 |
Zheng Wei, Beijing CN
Patent application number | Description | Published |
---|---|---|
20150346154 | INNER DETECTING DEVICE FOR SUBSEA OIL AND GAS PIPELINE - An inner detecting device for subsea oil and gas pipeline includes a support shaft defining a sealed chamber therein; a packer cup coupled to the support shaft; a hinge assembly coupled to the support shaft, swinging with respect to the support shaft in a radial direction and sliding with respect to the support shaft in an axial direction; a magnetic detector connected to the hinge assembly to move with respect to the support shaft in the radial and axial directions, and the magnetic detector tending to move away from the support shaft in the radial direction; a battery pack; an electric recorder electrically connected to the battery pack; and a mileage recorder recording a travel distance of the inner detecting device within the pipeline. | 12-03-2015 |